- Home
- LESL vs UNCY Comparison
LESL vs UNCY Comparison
Compare LESL & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- UNCY
- Stock Information
- Founded
- LESL 1963
- UNCY 2016
- Country
- LESL United States
- UNCY United States
- Employees
- LESL N/A
- UNCY 22
- Industry
- LESL Diversified Commercial Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- UNCY Health Care
- Exchange
- LESL Nasdaq
- UNCY Nasdaq
- Market Cap
- LESL 66.9M
- UNCY 121.9M
- IPO Year
- LESL 2020
- UNCY 2021
- Fundamental
- Price
- LESL $2.95
- UNCY $5.67
- Analyst Decision
- LESL Hold
- UNCY Strong Buy
- Analyst Count
- LESL 9
- UNCY 5
- Target Price
- LESL $33.25
- UNCY $41.60
- AVG Volume (30 Days)
- LESL 132.8K
- UNCY 536.3K
- Earning Date
- LESL 11-25-2025
- UNCY 11-12-2025
- Dividend Yield
- LESL N/A
- UNCY N/A
- EPS Growth
- LESL N/A
- UNCY N/A
- EPS
- LESL N/A
- UNCY N/A
- Revenue
- LESL $1,250,568,000.00
- UNCY N/A
- Revenue This Year
- LESL N/A
- UNCY N/A
- Revenue Next Year
- LESL N/A
- UNCY $19,392.60
- P/E Ratio
- LESL N/A
- UNCY N/A
- Revenue Growth
- LESL N/A
- UNCY N/A
- 52 Week Low
- LESL $2.80
- UNCY $3.71
- 52 Week High
- LESL $72.60
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- LESL 43.78
- UNCY 70.74
- Support Level
- LESL $3.04
- UNCY $4.28
- Resistance Level
- LESL $3.35
- UNCY $5.54
- Average True Range (ATR)
- LESL 0.29
- UNCY 0.40
- MACD
- LESL -0.13
- UNCY 0.07
- Stochastic Oscillator
- LESL 15.29
- UNCY 78.56
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.